The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Incidence, risk factors, and outcomes of immune-related adverse events (irAEs) in a prospective, pan-tumor population.
 
Aanika Balaji
No Relationships to Disclose
 
Stephanie Leigh Alden
No Relationships to Disclose
 
Howard Li
No Relationships to Disclose
 
Kabeer Munjal
No Relationships to Disclose
 
Evan J. Lipson
Honoraria - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; CareDX; Eisai; Genentech; HUYA Bioscience International; Immunocore; Instil Bio; Merck; Natera; Nektar; Novartis; OncoSec; Pfizer; Rain Therapeutics; Regeneron; Replimune; Sanofi
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst); Regeneron (Inst); Sanofi (Inst)
 
Jarushka Naidoo
Honoraria - Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Daiichi Sankyo/Lilly; Elevation Oncology; Kaleido Biosciences; Merck; Mirati Therapeutics; NGM Biopharmaceuticals; Pfizer; Roche/Genentech; Takeda
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca/MedImmune; Bristol-Myers Squibb; Daiichi Sankyo/Lilly; Elevation Oncology; Kaleido Biosciences; Merck; Merck KGaA; Mirati Therapeutics; NGM Biopharmaceuticals; Pfizer; Roche/Genentech; Takeda
Research Funding - Amgen (Inst); AstraZeneca (Inst); Merck (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - AstraZeneca/MedImmune; Bristol-Myers Squibb
 
Laura Cappelli
No Relationships to Disclose
 
Yasser Ged
No Relationships to Disclose
 
Jean H. Hoffman-Censits
Honoraria - Clovis Oncology; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech; Roche/Genentech
Consulting or Advisory Role - AstraZeneca; Foundation medicine; Roche/Genentech; Seagen
Research Funding - Foundation Medicine; Genentech; Genentech; Sanofi
Travel, Accommodations, Expenses - Roche/Genentech
 
Rajat Mohindra
Employment - Novartis (I); Roche
Stock and Other Ownership Interests - Novartis (I); Roche
Research Funding - Roche
Travel, Accommodations, Expenses - Roche
 
Rachel Garonce-Hediger
Employment - F. Hoffmann LaRoche
Stock and Other Ownership Interests - F. Hoffmann LaRoche
Travel, Accommodations, Expenses - F. Hoffmann LaRoche
 
Tanguy Y. Seiwert
Honoraria - Coherus Biosciences; Merck; Nanobiotix
Consulting or Advisory Role - Bayer; BioNTech SE; BostonGene; CUE Biopharma; Innate Pharma; IO Biotech; Merck; Nanobiotix; Nektar; Sanofi; VIR Biotechnology
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Cue Biopharma (Inst); Dracen (Inst); Genentech/Roche (Inst); Merck (Inst); Nanobiotix (Inst); Regeneron (Inst)
Travel, Accommodations, Expenses - BostonGene; Coherus Biosciences; Nanobiotix
 
Sanjay Bansal
Employment - Roche
Research Funding - Roche
 
Laura Tang
Employment - Genentech
Stock and Other Ownership Interests - Bayer; Exact Sciences (I); Genentech
Travel, Accommodations, Expenses - Genentech; Genentech
 
G Scott Chandler
Employment - Roche/Genentech
Stock and Other Ownership Interests - Roche/Genentech
Research Funding - Roche/Genentech
Patents, Royalties, Other Intellectual Property - Patent pending as co-inventor of novel biomarker work performed as Roche employee
Travel, Accommodations, Expenses - Roche/Genentech
 
Mark Yarchoan
Leadership - Adventris Pharmaceuticals
Stock and Other Ownership Interests - Adventris Pharmaceuticals
Consulting or Advisory Role - AstraZeneca; Eisai; Exelixis; Genentech/Roche; Hepion Pharmaceuticals; Replimune
Research Funding - Bristol-Myers Squibb (Inst); Exelixis (Inst); Incyte (Inst); Merck (Inst)
(OPTIONAL) Uncompensated Relationships - Merck
 
Chester Kao
No Relationships to Disclose